ACACIA PHARMA

BYFAVO

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

ACACIA PHARMA

Byfavo HCPCS:

J2249

HCPCS Code Descriptor:

Injection, remimazolam, 1 mg

Category:

J Code

Byfavo NDCs:

71390-0011-00, 71390-0011-11

Primary Type:

Sedative

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Byfavo CPT Codes:

Potential CPT administration codes for Byfavo can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

71390-0011-00, 71390-0011-11

About Byfavo:

BYFAVO is a Sedative drug manufactured by ACACIA PHARMA and administered via the Intravenous route of administration. The J Code: J2249 is aligned to the drug BYFAVO.

BYFAVO belongs to a class of drugs known as benzodiazepines and is used to help patients relax before minor surgeries and other medical procedures. BYFAVO is produced by Acacia pharma and is aligned to the HCPCS code J2249.

ACCESS PRICING AND MORE BY REGISTERING

J2249 Added Date:

July 1, 2023

J2249 Effective Date:

July 1, 2023

J2249 Termination Date:

HCPCS Active

Byfavo billing and coding information can be found through Acacia Pharma at the link below:
Our team did not identify a source for Byfavo patient assistance information. Please reach out to our team if you feel that this is a mistake.
BYFAVO prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for BYFAVO. Please check back in a few weeks.

BuyandBill.com Drug Alert: